欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号ES/H/0836/002
药品名称Suprophage XR 50/1000 mg modified-release tablets
活性成分
    • metformin hydrochloride 1000.0 mg
    • SITAGLIPTIN 50.0 mg
剂型Prolonged-release tablet
上市许可持有人Galenicum Health, S.L. Calle de San Gabriel, 50 Polígono Industrial de Esplugues de Llobregat Esplugues de Llobregat, 08950, Barcelona Spain
参考成员国 - 产品名称Spain (ES)
互认成员国 - 产品名称
    • Romania (RO)
      Suprophage XR 50 mg/1000 mg comprimate cu eliberare prelungită
许可日期2023/06/13
最近更新日期2023/06/14
药物ATC编码
    • A10BD07 metformin and sitagliptin
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase